Quest Laborato.

45
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0TNW01017
  • NSEID: QUESTLAB
  • BSEID:
INR
99.00
-2.1 (-2.08%)
BSENSE

Jan 19

BSE+NSE Vol: 61200

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 25.92% vs 33.94% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 2.69% vs 97.32% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 16.21% vs 34.00% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 34.40% vs 100.08% in Mar 2024

Compare Profit and Loss Results of Quest Laborato.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
103.00
473.00
-370.00
-78.22%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
103.00
473.00
-370.00
-78.22%
Expenditure (Ex Depriciation)
Stock Adjustments
-4.00
-10.00
6.00
60.00%
Raw Materials Consumed
83.00
472.00
-389.00
-82.42%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
4.00
0.00
4.00
0%
Operating Expenses
0.00
1.00
-1.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
3.00
-3.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
2.00
0.00
2.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
87.00
471.00
-384.00
-81.53%
Operating Profit (PBDIT) excl Other Income
15.00
2.00
13.00
650.00%
Other Income
4.00
9.00
-5.00
-55.56%
Operating Profit (PBDIT)
20.00
12.00
8.00
66.67%
Interest
0.00
4.00
-4.00
-100.00%
Profit before Depriciation and Tax
19.00
8.00
11.00
137.50%
Depreciation
0.00
1.00
-1.00
-100.00%
Profit Before Taxation & Exceptional Items
18.00
6.00
12.00
200.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
18.00
6.00
12.00
200.00%
Provision for Tax
5.00
2.00
3.00
150.00%
Profit After Tax
13.00
4.00
9.00
225.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
14.00
53.00
-39.00
-73.58%
Profit Available for appropriations
27.00
57.00
-30.00
-52.63%
Appropriations
27.00
57.00
-30.00
-52.63%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
8.28
1.42
6.86
483.10%
Profit And Loss - Net Sales
Net Sales 103.97 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 25.92% vs 33.94% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 15.98 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 2.69% vs 97.32% in Mar 2024

Profit And Loss - Interest
Interest 0.91 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 16.21% vs 34.00% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 13.57 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 34.40% vs 100.08% in Mar 2024